Hormone replacement therapy increases the risk of breast cancer

Annals of the New York Academy of Sciences

Volumn 833, Issue , 1997, Pages 129-136

  Colditz, Graham A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Charming Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WEIGHT; BREAST CANCER; BREAST DISEASE; CANCER RISK; CONFERENCE PAPER; FAMILY HISTORY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MATERNAL AGE; MENARCHE; MENOPAUSE; PARITY; RADIATION EXPOSURE; RISK FACTOR; UNITED STATES;

EID: 0031590784     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48598.x     Document Type: Conference Paper

References (17)

1. KOSARY, C., L. RIES, B. MILLER, B. HANKEY, A. HARRAS & B. EDWARDS. 1995. SEER Cancer Statistics Review, 1973-1992: Tables and Graphs. NIH Publication No. 962789. National Cancer Institute. Bethesda, MD.
2. BLACK, W., R. NEASE & A. TOSTESON. 1995. Perception of breast cancer risk and screening effectiveness in women younger than 50 years of age. J. Natl. Cancer Inst. 87: 720-731.
3. COLDITZ, G. A., S. E. HANKINSON, D. J. HUNTER et al. 1995. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 332: 1589-1593.
4. PIKE, M. C., M. D. KRAILO, B. E. HENDERSON, J. T. CASAGRANDE & D. G. HOEL. 1983. "Hormonal" risk factors, "breast tissue age" and the age-incidence of breast cancer. Nature 303: 767-770.
5. ROSNER, B. & G. COLDITZ. 1996. Extended mathematical model of breast cancer incidence in the Nurses' Health Study. J. Natl. Cancer Inst. 88: 359-364.
6. MOOLGAVKAR, S. H., N. E. DAY & R. G. STEVENS. 1980. Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. J. Natl. Cancer Inst. 65: 559-569.
7. KEY, T. J. & M. C. PIKE. 1988. The role of estrogens and progestogens in the epidemiology of and prevention of breast cancer. Eur. J. Cancer Clin. Oncol. 24: 29-43.
8. KING, M.-C., S. ROWELL & S. M. LOVE. 1993. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 269: 1975-1980.
9. TAKUNAGA, M., C. E. LAND, S. TOKUOKA, I. NISHIMORI, M. SODA & S. AKIBA. 1994. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat. Res. 138: 209-123.
10. LONDON, S. J., J. L. CONNOLLY, S. J. SCHNITT & G. A. COLDITZ. 1992. A prospective study of benign breast disease and the risk of breast cancer. JAMA 267: 941-944.
11. COLDITZ, G. A. 1995. Fat, estrogens, and the time frame for prevention of breast cancer [editorial]. Epidemiology 6: 209-211.
12. ROSNER, B., G. A. COLDITZ & W. C. WILLETT. 1994. Reproductive risk factors in a prospective study of breast cancer: The Nurses' Health Study. Am. J. Epidemiol. 139: 819-835.
13. MUIR, C., J. WATERHOUSE, T. MACK, J. POWELL & S. WHELAN, Eds. 1987. Cancer Incidence in Five Continents. LARC Scientific Publications No. 88. Vol. 5. International Agency for Research on Cancer. Lyon, France.
14. MIYAJI, N. T. & M. LOCK. 1994. Monitoring motherhood: Sociocultural and historical aspects of maternal and child health in Japan. Daedalus 134(4): 87-112.
15. WORLD BANK. 1993. Social Indicators of Development 1993. Johns Hopkins University Press. Baltimore, MD.
16. SEOW, A., S. W. DUFFY, M. A. McGEE, J. LEE & H. P. LEE. 1996. Breast cancer in Singapore: Trends in incidence, 1968-1992. Int. J. Epidemiol. 25: 40-45.
17. JURGENS, R. J., L. DOWNEY, W. ABERNATHY, N. CUTLER & J. CONRAD. 1992. A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy. Am. J. Obstet. Gynecol. 167: 459-460.